These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 33406628)

  • 1. Gut Microbiota Dysbiosis Is Associated with Elevated Bile Acids in Parkinson's Disease.
    Li P; Killinger BA; Ensink E; Beddows I; Yilmaz A; Lubben N; Lamp J; Schilthuis M; Vega IE; Woltjer R; Pospisilik JA; Brundin P; Brundin L; Graham SF; Labrie V
    Metabolites; 2021 Jan; 11(1):. PubMed ID: 33406628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of Gut Microbial Metabolites in the Systemic Circulation of Patients with Parkinson's Disease.
    Chen SJ; Chen CC; Liao HY; Wu YW; Liou JM; Wu MS; Kuo CH; Lin CH
    J Parkinsons Dis; 2022; 12(4):1219-1230. PubMed ID: 35342048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing the Hindgut Carbohydrate/Protein Ratio by Cecal Infusion of Corn Starch or Casein Hydrolysate Drives Gut Microbiota-Related Bile Acid Metabolism To Stimulate Colonic Barrier Function.
    Pi Y; Mu C; Gao K; Liu Z; Peng Y; Zhu W
    mSystems; 2020 Jun; 5(3):. PubMed ID: 32487741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease.
    Lin CH; Chen CC; Chiang HL; Liou JM; Chang CM; Lu TP; Chuang EY; Tai YC; Cheng C; Lin HY; Wu MS
    J Neuroinflammation; 2019 Jun; 16(1):129. PubMed ID: 31248424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome.
    Hill-Burns EM; Debelius JW; Morton JT; Wissemann WT; Lewis MR; Wallen ZD; Peddada SD; Factor SA; Molho E; Zabetian CP; Knight R; Payami H
    Mov Disord; 2017 May; 32(5):739-749. PubMed ID: 28195358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut Microbiota Dysbiosis Is Associated with Altered Bile Acid Metabolism in Infantile Cholestasis.
    Wang Y; Gao X; Zhang X; Xiao Y; Huang J; Yu D; Li X; Hu H; Ge T; Li D; Zhang T
    mSystems; 2019 Dec; 4(6):. PubMed ID: 31848302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of bile acids and the gut microbiota: learning from the differences in
    Cheng S; Zhu L; Faden HS
    Physiol Genomics; 2019 Jun; 51(6):218-223. PubMed ID: 31074701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
    Sun MF; Shen YQ
    Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD.
    Jiao N; Baker SS; Chapa-Rodriguez A; Liu W; Nugent CA; Tsompana M; Mastrandrea L; Buck MJ; Baker RD; Genco RJ; Zhu R; Zhu L
    Gut; 2018 Oct; 67(10):1881-1891. PubMed ID: 28774887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Appendix in Parkinson's Disease: From Vestigial Remnant to Vital Organ?
    Killinger B; Labrie V
    J Parkinsons Dis; 2019; 9(s2):S345-S358. PubMed ID: 31609697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of the Gut Microbiota in Bile Acid Metabolism.
    Ramírez-Pérez O; Cruz-Ramón V; Chinchilla-López P; Méndez-Sánchez N
    Ann Hepatol; 2017 Nov; 16(Suppl. 1: s3-105.):s15-s20. PubMed ID: 29080339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut Microbiota Differs Between Parkinson's Disease Patients and Healthy Controls in Northeast China.
    Li C; Cui L; Yang Y; Miao J; Zhao X; Zhang J; Cui G; Zhang Y
    Front Mol Neurosci; 2019; 12():171. PubMed ID: 31354427
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway.
    Sun MF; Zhu YL; Zhou ZL; Jia XB; Xu YD; Yang Q; Cui C; Shen YQ
    Brain Behav Immun; 2018 May; 70():48-60. PubMed ID: 29471030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated Multi-Cohort Analysis of the Parkinson's Disease Gut Metagenome.
    Boktor JC; Sharon G; Verhagen Metman LA; Hall DA; Engen PA; Zreloff Z; Hakim DJ; Bostick JW; Ousey J; Lange D; Humphrey G; Ackermann G; Carlin M; Knight R; Keshavarzian A; Mazmanian SK
    Mov Disord; 2023 Mar; 38(3):399-409. PubMed ID: 36691982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The gut microbiome in Parkinson's disease: A culprit or a bystander?
    Keshavarzian A; Engen P; Bonvegna S; Cilia R
    Prog Brain Res; 2020; 252():357-450. PubMed ID: 32247371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The gallbladder and vermiform appendix influence the assemblage of intestinal microorganisms.
    Chen J; Sali A; Vitetta L
    Future Microbiol; 2020 May; 15():541-555. PubMed ID: 32478580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease.
    Dodiya HB; Forsyth CB; Voigt RM; Engen PA; Patel J; Shaikh M; Green SJ; Naqib A; Roy A; Kordower JH; Pahan K; Shannon KM; Keshavarzian A
    Neurobiol Dis; 2020 Feb; 135():104352. PubMed ID: 30579705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls.
    Unger MM; Spiegel J; Dillmann KU; Grundmann D; Philippeit H; Bürmann J; Faßbender K; Schwiertz A; Schäfer KH
    Parkinsonism Relat Disord; 2016 Nov; 32():66-72. PubMed ID: 27591074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay between bile acids and the gut microbiota promotes intestinal carcinogenesis.
    Wang S; Dong W; Liu L; Xu M; Wang Y; Liu T; Zhang Y; Wang B; Cao H
    Mol Carcinog; 2019 Jul; 58(7):1155-1167. PubMed ID: 30828892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of the Gut Microbiota in Bile Acid Metabolism.
    Ramírez-Pérez O; Cruz-Ramón V; Chinchilla-López P; Méndez-Sánchez N
    Ann Hepatol; 2017 Nov; 16 Suppl 1():S21-S26. PubMed ID: 31196631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.